KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $457.0 million.

  • Medtronic's Free Cash Flow fell 1750.9% to $457.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $5.2 billion, marking a year-over-year decrease of 532.82%. This contributed to the annual value of $5.2 billion for FY2025, which is 28.85% down from last year.
  • As of Q4 2025, Medtronic's Free Cash Flow stood at $457.0 million, which was down 1750.9% from $584.0 million recorded in Q3 2025.
  • In the past 5 years, Medtronic's Free Cash Flow ranged from a high of $2.4 billion in Q2 2024 and a low of $200.0 million during Q4 2023
  • Its 5-year average for Free Cash Flow is $1.3 billion, with a median of $1.3 billion in 2021.
  • In the last 5 years, Medtronic's Free Cash Flow soared by 173214.29% in 2021 and then plummeted by 6661.1% in 2023.
  • Over the past 5 years, Medtronic's Free Cash Flow (Quarter) stood at $1.5 billion in 2021, then plummeted by 60.01% to $599.0 million in 2022, then tumbled by 66.61% to $200.0 million in 2023, then skyrocketed by 177.0% to $554.0 million in 2024, then dropped by 17.51% to $457.0 million in 2025.
  • Its Free Cash Flow stands at $457.0 million for Q4 2025, versus $584.0 million for Q3 2025 and $2.1 billion for Q2 2025.